Loading data for ALC — first visit, this takes a few seconds.

Alcon Inc. (ALC)

NYSE: ALC · 即時價格 · USD

66.55

-1.88 (-2.75%)

收盤價： Sep 10, 2026, 3:59 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

-2.75% (1D)

買價	0
市值	32.2B
營收 (ttm)	10.9B
淨利（ttm）	643M
	0.70
	1.27
	52.4
	16.73
P/B (ttm)	1.49
P/S (ttm)	2.96
財報日期	Nov 10, 2026

賣價	0
成交量	1,565,650
20 日平均成交量	1,918,178
開盤價	67.42
前收盤價	68.43
當日區間	66.53 - 67.69
52 週範圍	61.84 - 87.64
分析師	n/a
目標價	n/a
股利	$0.36 (0.53%)
除息日	May 6, 2026

關於 ALC

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract p...

[閱讀更多]

產業 Medical Instruments & Supplies

類股 Healthcare

IPO 日期 Apr 9, 2019

員工 25,000

證券交易所 NYSE

股票代號 ALC

網站 https://www.alcon.com

完整的公司簡介

財務表現

Alcon 在 2025 年的營收為 10.4B，較前一年的 9.91B 增加 4.94%。淨利為 980M，較前期減少 -3.73%。

財務報表

財報驚奇

Alcon 已於 Aug 10, 2026 公布季度財報：

營收為 $2.82B 低於預期 $0, 年增 8.74% 成長.
每股盈餘為 0.84 超出預期 0.08, 年增 10.53% 成長.

下次財報發布

Alcon Inc. 的下次財報預計於 Nov 10, 2026, 盤中。
分析師預估營收 ... 升級

價格為何變動

新聞動態

6 天前 · Zacks

Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?

Alcon's acquisitions, partnerships and new product launches support growth, but tariffs and intense competition remain key risks.

1 週前 · Zacks

Are Options Traders Betting on a Big Move in Alcon Stock?

Investors need to pay close attention to ALC stock based on the movements in the options market lately.

1 週前 · Simply Wall St.

Alcon (SWX:ALC), What Is Behind The Fresh Attention?

Alcon stock reacts to US Medicaid drug pricing agreement New US Medicaid drug pricing agreements involving Alcon (SWX:ALC) and eight other healthcare companies have put the stock in focus for investor...

1 週前 · Zacks

Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers

Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.

1 週前 · BioPharma Dive

Mid-cap biotechs join Trump’s latest round of drug pricing deals

Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren’t expected to meaningfully impact drugmaker profits.

第 1 頁，共 2 頁

Alcon Inc. (ALC)

Alcon Inc.（ALC）股價、分析與資料

關於 ALC

財務表現

財報驚奇

下次財報發布

價格為何變動

新聞動態

6 天前 · Zacks

1 週前 · Zacks

1 週前 · Simply Wall St.

1 週前 · Zacks

1 週前 · BioPharma Dive